Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kaletra and Maraviroc in ART-naïve HIV patients
NCT01068873Phase 4Terminated
- Sponsor
- Temple University
- Start
- Apr 2010
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lopinavir + ritonavir, maraviroc in human immunodeficiency virus infection (HIV), sponsored by Temple University. Started Apr 2010; status: terminated.
02
Drugs
lopinavir + ritonavirmaraviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01068873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01068873.